Incidence and Survival for Head and Neck Cancers in Estonia, 1996–2016: A Population-Based Study

References

• Ferlay J, Ervik M, Lam F, et al. Global cancer observatory. international agency for research on cancer. cancer today multibars; 2018. Available from: https://gco.iarc.fr/today/online-analysis-multi-bars. Accessed 522, 2020.
   Google Scholar
• Simard EP, Torre LA, Jemal A. International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol. 2014;50(5):387–403. doi:10.1016/j.oraloncology.2014.01.016.24530208
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550–4559. doi:10.1200/JCO.2013.50.3870.24248688
   PubMed Web of Science ®Google Scholar
• Thompson-Harvey A, Yetukuri M, Hansen AR, et al. Rising incidence of late-stage head and neck cancer in the United States. Cancer. 2020;126(5):1090–1101. doi:10.1002/cncr.32583.31722124
   PubMed Web of Science ®Google Scholar
• Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA. 2017;317(13):1338–1348. doi:10.1001/jama.2017.2719.28362912
   PubMed Web of Science ®Google Scholar
• Mirian C, Grønhøj C, Jensen DH, et al. Trends in thyroid cancer: retrospective analysis of incidence and survival in Denmark 1980–2014. Cancer Epidemiol. 2018;55:81–87. doi:10.1016/j.canep.2018.05.009.29852396
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136(9):2187–2195. doi:10.1002/ijc.29251.25284703
   PubMed Web of Science ®Google Scholar
• Sant M, Aareleid T, Berrino F, et al. EUROCARE-3: survival of cancer patients diagnosed 1990–94 - results and commentary. Ann Oncol. 2003;14:61–118. doi:10.1093/annonc/mdg754.
   PubMed Web of Science ®Google Scholar
• Gatta G, Botta L, Sánchez MJ, et al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study. Eur J Cancer. 2015;51(15):2130–2143. doi:10.1016/j.ejca.2015.07.043.26421817
   PubMed Web of Science ®Google Scholar
• Aareleid T, Zimmermann ML, Baburin A, Innos K. Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study. BMC Cancer. 2017;17(1):1–10. doi:10.1186/s12885-017-3605-x.28049525
   PubMed Web of Science ®Google Scholar
• Ojamaa K, Innos K, Baburin A, Everaus H, Veerus P. Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014. BMC Cancer. 2018;18(1):1–9. doi:10.1186/s12885-018-5006-1.29291726
   PubMed Web of Science ®Google Scholar
• Innos K, Baburin A, Kotsar A, Eiche IE, Lang K. Prostate cancer incidence, mortality and survival trends in Estonia, 1995–2014. Scand J Urol. 2017;51(6):442–449. doi:10.1080/21681805.2017.1392600.29092653
   PubMed Web of Science ®Google Scholar
• Innos K, Sepp T, Baburin A, et al. Increasing kidney cancer incidence and survival in Estonia: role of age and stage. Acta Oncol (Madr). 2019;58(1):21–28. doi:10.1080/0284186X.2018.1512158.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries, et al. International Rules for Multiple Primary Cancers (ICD-O). 3rd ed. Lyon: International Agency for Research on Cancer; 2004.
   Google Scholar
• Ederer F, Heise H. Instructions to IBM 650 Programmers in Processing Survival Computations. Methodological Note No. 10. Bethesda, MD, USA: National Cancer Institute, End Results Evaluation Section; 1959.
   Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004;40(15):2307–2316. doi:10.1016/j.ejca.2004.07.002.15454257
   PubMed Web of Science ®Google Scholar
• Dickman PW, Coviello E. Estimating and modeling relative survival. Stata J. 2015;15(1):186–215. doi:10.1177/1536867X1501500112
   Web of Science ®Google Scholar
• National Institute for Health Development. Health statistics and health research database. Available from: http://pxweb.tai.ee/PXWeb2015/index_en.html. Accessed 522, 2020.
   Google Scholar
• Zafereo ME, Xu L, Dahlstrom KR, et al. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol. 2016;56:47–53. doi:10.1016/j.oraloncology.2016.03.003.27086486
   PubMed Web of Science ®Google Scholar
• Padrik P, Valter A, Valter E, Baburin A, Innos K. Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study. Acta Oncol (Madr). 2017;56(1):52–58. doi:10.1080/0284186X.2016.1243804.
   PubMed Web of Science ®Google Scholar
• Monteiro LS, Antunes L, Bento MJ, Warnakulasuriya S. Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal. J Oral Pathol Med. 2013;42(4):345–351. doi:10.1111/jop.12010.23034073
   PubMed Web of Science ®Google Scholar
• Blomberg M, Nielsen A, Munk C, Kjaer SK. Trends in head and neck cancer incidence in Denmark, 1978–2007: focus on human papillomavirus associated sites. Int J Cancer. 2011;129(3):733–741. doi:10.1002/ijc.25699.20878955
   PubMed Web of Science ®Google Scholar
• Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol. 2006;7(2):149–156. doi:10.1016/S1470-2045(06)70577-0.16455479
   PubMed Web of Science ®Google Scholar
• Braakhuis BJM, Leemans CR, Visser O. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol. 2014;50(7):670–675. doi:10.1016/j.oraloncology.2014.03.008.24735546
   PubMed Web of Science ®Google Scholar
• Jakobsen KK, Grønhøj C, Jensen DH, et al. Increasing incidence and survival of head and neck cancers in Denmark: a nation-wide study from 1980 to 2014. Acta Oncol (Madr). 2018;57(9):1143–1151. doi:10.1080/0284186X.2018.1438657.
   PubMed Web of Science ®Google Scholar
• Peller M, Katalinic A, Wollenberg B, Teudt IU, Meyer JE. Epidemiology of laryngeal carcinoma in Germany, 1998–2011. Eur Arch Otorhinolaryngol. 2016;273(6):1481–1487. doi:10.1007/s00405-016-3922-8.26879991
   PubMed Web of Science ®Google Scholar
• Mifsud M, Eskander A, Irish J, et al. Evolving trends in head and neck cancer epidemiology: Ontario, Canada 1993–2010. Head Neck. 2017;39(9):1770–1778. doi:10.1002/hed.24829.28557276
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–4301. doi:10.1200/JCO.2011.36.4596.21969503
   PubMed Web of Science ®Google Scholar
• Haeggblom L, Attoff T, Yu J, et al. Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000–2016 in the Stockholm region and Sweden. Head Neck. 2019;41(6):1583–1590. doi:10.1002/hed.25585.30584688
   PubMed Web of Science ®Google Scholar
• Ramqvist T, Dalianis T. An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and prevention. Anticancer Res. 2011;31:1515–1519.21617204
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006;24:11–25. doi:10.1016/j.vaccine.2006.05.111.
   Web of Science ®Google Scholar
• de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–670. doi:10.1002/ijc.30716.28369882
   PubMed Web of Science ®Google Scholar
• Stein AP, Saha S, Kraninger JL, et al. Prevalence of human papillomavirus in oropharyngeal cancer: a systematic review. Cancer J. 2015;21(3):138–146. doi:10.1097/PPO.000000000000011526049691
   PubMed Web of Science ®Google Scholar
• Innos K, Reima H, Baburin A, Paapsi K, Aareleid T, Soplepmann J. Subsite- and stage-specific colorectal cancer trends in Estonia prior to implementation of screening. Cancer Epidemiol. 2018;52:112–119. doi:10.1016/j.canep.2017.12.016.29294434
   PubMed Web of Science ®Google Scholar
• Uusküla A, Reile R, Rezeberga D, et al. The prevalence of genital warts in the baltic countries: findings from national cross-sectional surveys in Estonia, Latvia and Lithuania. Sex Transm Infect. 2015;91(1):55–60. doi:10.1136/sextrans-2014-051540.25104496
   PubMed Web of Science ®Google Scholar
• Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany. J Cancer Res Clin Oncol. 2012;138(3):431–437. doi:10.1007/s00432-011-1118-6.22167338
   PubMed Web of Science ®Google Scholar
• Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MWJ. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf). 2005;62(2):156–162. doi:10.1111/j.1365-2265.2004.02187.x.15670190
   PubMed Web of Science ®Google Scholar
• Verkooijen HM, Fioretta G, Pache JC, et al. Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control. 2003;14(1):13–17. doi:10.1023/A:1022593923603.12708720
   PubMed Web of Science ®Google Scholar
• Larson SD, Jackson LN, Riall TS, et al. Increased incidence of well-differentiated thyroid cancer associated with hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg. 2007;204(5):764–773. doi:10.1016/j.jamcollsurg.2006.12.037.17481480
   PubMed Web of Science ®Google Scholar
• Dijkstra B, Prichard RS, Lee A, et al. Changing patterns of thyroid carcinoma. Ir J Med Sci. 2007;176(2):87–90. doi:10.1007/s11845-007-0041-y.17486294
   PubMed Web of Science ®Google Scholar
• Mack WJ, Preston-Martin S, Bernstein L, Qian D. Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol. 2002;12(6):395–401. doi:10.1016/S1047-2797(01)00281-2.12160598
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Platz EA, Beane Freeman LE, et al. Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev. 2011;20(3):464–472. doi:10.1158/1055-9965.EPI-10-1220.21266520
   PubMed Web of Science ®Google Scholar
• Dyntar D, Lorez M, Diebold J. Incidence-based mortality trends for thyroid cancer: is there a « true » increase in incidence of thyroid cancer in Switzerland ? Schweizer Krebsbulletin. 2018;3/2018:281–288.
   Google Scholar
• Li M, Maso LD, Vaccarella S. Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 2020;8(6):468–470. doi:10.1016/S2213-8587(20)30115-7.32445733
   PubMed Web of Science ®Google Scholar
• Ferlay J, Bray F, Steliarova-Foucher E, Forman D. CI5 I-X: cancer incidence in five continents, volumes I to X 2014. Available from: https://ci5.iarc.fr/CI5I-X/Default.aspx. Accessed 522, 2020.
   Google Scholar
• Schmidt Jensen J, Grønhøj C, Mirian C, et al. Incidence and survival of thyroid cancer in children, adolescents, and young adults in Denmark: a nationwide study from 1980 to 2014. Thyroid. 2018;28(9):1128–1133. doi:10.1089/thy.2018.0067.29943676
   PubMed Web of Science ®Google Scholar
• Danckert B, Ferlay J, Engholm G, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the nordic countries, version 8.2 (26.03.2019). Assoc Nord Cancer Regist Danish Cancer Soc. 2019.
   Google Scholar
• Kowalski LP, Carvalho AL. Influence of time delay and clinical upstaging in the prognosis of head and neck cancer. Oral Oncol. 2001;37(1):94–98. doi:10.1016/S1368-8375(00)00066-X.11120489
   PubMed Web of Science ®Google Scholar
• Talani C, Mäkitie A, Beran M, Holmberg E, Laurell G, Farnebo L. Early mortality after diagnosis of cancer of the head and neck – a population-based nationwide study. PLoS One. 2019;14(10):1–18. doi:10.1371/journal.pone.0223154.
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551.30620402
   PubMed Web of Science ®Google Scholar
• Dittberner A, Friedl B, Wittig A, et al. Gender disparities in epidemiology, treatment, and outcome for head and neck cancer in germany: a population-based long-term analysis from 1996 to 2016 of the thuringian cancer registry. Cancers (Basel). 2020;12(11):1–14. doi:10.3390/cancers12113418.
   Web of Science ®Google Scholar
• Innos K, Padrik P, Valvere V, Aareleid T. Sex differences in cancer survival in Estonia: a population-based study. BMC Cancer. 2015;15(1):1–9. doi:10.1186/s12885-015-1080-9.25971837
   PubMed Web of Science ®Google Scholar
• Beynon RA, Lang S, Schimansky S, et al. Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: results from head and neck 5000, a prospective observational cohort of people with head and neck cancer. Int J Cancer. 2018;143(5):1114–1127. doi:10.1002/ijc.31416.29607493
   PubMed Web of Science ®Google Scholar
• Du E, Mazul AL, Farquhar D, et al. Long-term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status. Laryngoscope. 2019;129(11):2506–2513. doi:10.1002/lary.27807.30637762
   PubMed Web of Science ®Google Scholar
• Bøje CR, Dalton SO, Primdahl H, et al. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database. Radiother Oncol. 2014;110(1):91–97. doi:10.1016/j.radonc.2013.11.009.24412015
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35. doi:10.1056/NEJMoa0912217.20530316
   PubMed Web of Science ®Google Scholar
• Schimansky S, Lang S, Beynon R, et al. Association between comorbidity and survival in head and neck cancer: results from head and neck 5000. Head Neck. 2019;41(4):1053–1062. doi:10.1002/hed.25543.30549147
   PubMed Web of Science ®Google Scholar
• Paleri V, Wight RG, Silver CE, et al. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol. 2010;46(10):712–719. doi:10.1016/j.oraloncology.2010.07.008.20850371
   PubMed Web of Science ®Google Scholar
• Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL. Prognostic importance of comorbidity in a hospital-based cancer registry. J Am Med Assoc. 2004;291(20):2441–2447. doi:10.1001/jama.291.20.2441.
   PubMed Web of Science ®Google Scholar
• Leoncini E, Ricciardi W, Cadoni G, et al. Adult height and head and neck cancer: a pooled analysis within the INHANCE consortium. Head Neck. 2014;36:1391. doi:10.1002/HED.
   Google Scholar
• Minicozzi P, Van Eycken L, Molinie F, et al. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer. Int J Cancer. 2019;144(9):2118–2127. doi:10.1002/ijc.31974.30411340
   PubMed Web of Science ®Google Scholar
• Grau C, Defourny N, Malicki J, et al. Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol. 2014;112(2):155–164. doi:10.1016/j.radonc.2014.08.029.25443859
   PubMed Web of Science ®Google Scholar
• Graboyes EM, Kompelli AR, Neskey DM, et al. Association of treatment delays with survival for patients with head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 2019;145(2):166–177. doi:10.1001/jamaoto.2018.2716.30383146
   PubMed Web of Science ®Google Scholar
• Borras JM, Lievens Y, Dunscombe P, et al. The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis. Radiother Oncol. 2015;116(1):38–44. doi:10.1016/j.radonc.2015.04.018.25981052
   PubMed Web of Science ®Google Scholar